BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 19182773)

  • 21. Completion of the entire hepatitis C virus life cycle in genetically humanized mice.
    Dorner M; Horwitz JA; Donovan BM; Labitt RN; Budell WC; Friling T; Vogt A; Catanese MT; Satoh T; Kawai T; Akira S; Law M; Rice CM; Ploss A
    Nature; 2013 Sep; 501(7466):237-41. PubMed ID: 23903655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetically humanized mouse model for hepatitis C virus infection.
    Dorner M; Horwitz JA; Robbins JB; Barry WT; Feng Q; Mu K; Jones CT; Schoggins JW; Catanese MT; Burton DR; Law M; Rice CM; Ploss A
    Nature; 2011 Jun; 474(7350):208-11. PubMed ID: 21654804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
    Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
    J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
    Haid S; Windisch MP; Bartenschlager R; Pietschmann T
    J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
    Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
    Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
    Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
    J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverse CD81 proteins support hepatitis C virus infection.
    Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
    J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
    Gao R; Gao W; Xu G; Xu J; Ren H
    World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
    Sarhan MA; Chen AY; Michalak TI
    PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cell polarization on hepatitis C virus entry.
    Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
    J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.
    Ciesek S; Westhaus S; Wicht M; Wappler I; Henschen S; Sarrazin C; Hamdi N; Abdelaziz AI; Strassburg CP; Wedemeyer H; Manns MP; Pietschmann T; von Hahn T
    J Virol; 2011 Aug; 85(15):7613-21. PubMed ID: 21632765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion.
    Gerold G; Moeller R; Pietschmann T
    Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31427285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection and tight junction proteins: The ties that bind.
    Mailly L; Baumert TF
    Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
    Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
    Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Claudin association with CD81 defines hepatitis C virus entry.
    Harris HJ; Davis C; Mullins JG; Hu K; Goodall M; Farquhar MJ; Mee CJ; McCaffrey K; Young S; Drummer H; Balfe P; McKeating JA
    J Biol Chem; 2010 Jul; 285(27):21092-102. PubMed ID: 20375010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
    Martin DN; Uprichard SL
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10777-82. PubMed ID: 23754414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tree shrew bone marrow-derived mesenchymal stem cells express CD81, OCLN, and miR-122, facilitating the entire hepatitis C virus life cycle.
    Lu C; Feng Y; Sun X; Li N; Kuang D; Wang W; Tong P; Han Y; Xia X; Dai J
    J Med Virol; 2020 Dec; 92(12):3465-3474. PubMed ID: 32056224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.